309608
SBIRT Implementation: What drives success?
Building system level support for SBIRT is an important step for successful integration. Buy in is necessary from leaders in healthcare, associations, behavioral health treatment providers, payers, business leaders and purchasers, and others to support integration. Additionally, opportunities exist to support SBIRT integration as a critical strategy to improve patient care. Examples include the creation of health homes, implementation of healthcare reform, the final passing of the Parity rule, and the recognition of SBIRT as an effective strategy to prevent unhealthy substance use and improve health by the CDC, the American Congress of Obstetricians and Gynecologists, the Joint Commission, and the United States Preventive Services Task Force. Capitalizing on these opportunities will contribute to the success of SBIRT integration.
Learning Areas:
Administer health education strategies, interventions and programsImplementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Program planning
Learning Objectives:
List the individuals, organizations and systems important to engage for SBIRT implementation
Describe SBIRT implementation approaches that have been successful and challenging
Identify drivers that can impact the successful implementation of SBIRT practice in healthcare settings
Assess effective strategies for implementing SBIRT
Identify solutions to commonly perceived barriers of implementation
Keyword(s): Sustainability, Alcohol Use
Qualified on the content I am responsible for because: I have been the Director of Policy and Development for SBIRT Colorado since 2006 and have worked with a variety of healthcare settings and systems to integrate routine screening and brief intervention services for substance use as a standard of healthcare.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.